𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Molecular markers of pancreatic cancer: development and clinical relevance

✍ Scribed by Lucia C. Fry; Klaus Mönkemüller; Peter Malfertheiner

Publisher
Springer
Year
2008
Tongue
English
Weight
174 KB
Volume
393
Category
Article
ISSN
1435-2451

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Relevance of cyclin D1 and other molecul
Relevance of cyclin D1 and other molecular markers to cancer chemoprevention
✍ I. Bernard Weinstein 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 645 KB

Until recently studies on mutations in cellular genes implicated in multistage carcinogenc7sis have concentrated mainly on dominant acting mutations in cellular proto-oncogenes, genes that normally mediate agonistinduced signal transduction pathways, and recessive mutations in cellular tumor suppres

HPV involvement in tonsillar cancer: Pro
HPV involvement in tonsillar cancer: Prognostic significance and clinically relevant markers
✍ Eliška Rotnáglová; Ruth Tachezy; Martina Saláková; Bohumír Procházka; Eva Košl'a 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 194 KB 👁 1 views

## Abstract The association of high‐risk human papillomaviruses (HR HPVs) with tonsillar cancer (TC) has been documented. Because patients with HPV‐associated tumors show better survival rates, modification of their treatment regimen is being considered. It is therefore crucial to find markers for

Clinical use of tumor markers in pancrea
Clinical use of tumor markers in pancreatic carcinoma
✍ Maureen A. Chung; Helena R. Chang 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 473 KB

There is no ideal tumor marker for pancreatic carcinoma. Most of the tumor-associated antigens in this disease are cell surface mucins, such as CA19-9, TAG-72, CA242, CA50, CA195, and CA494. CA19-9 is the most promising marker. It is used for clinical and pathological diagnosis, prognosis, and respo